What is Theravance Biopharma's deferred taxes?

Theravance Biopharma (TBPH) reported deferred taxes of -$3M in Q1 2026.

How has Theravance Biopharma's deferred taxes changed year-over-year?

Theravance Biopharma's deferred taxes decreased by 61.9% year-over-year, from -$1.85M to -$3M.

What does deferred taxes mean?

Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.

Theravance Biopharma TBPH Deferred Taxes

Deferred Taxes at other companies

United TherapeuticsUTHR

$25.9M—

Aurinia PharmaceuticalsAUPH

$9.28M—

OrganonOGN

$3M+118%

Innoviva, Inc.INVA

$41.04M+17,199%

Bristol-Myers SquibbBMY

$161M-27.8%

EyePoint, Inc. EYPT

$369K+310%

Segments

By segment

See full

Single Reportable-$1.54M-175%

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$890.32M+68.7%

Enterprise value$642.72M+38.3%

P/E7.8×—

P/S8.1×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Reported directly by Theravance Biopharma in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxesAndTaxCredits.

The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Theravance Biopharma's deferred taxes?: Theravance Biopharma (TBPH) reported deferred taxes of -$3M in Q1 2026.
How has Theravance Biopharma's deferred taxes changed year-over-year?: Theravance Biopharma's deferred taxes decreased by 61.9% year-over-year, from -$1.85M to -$3M.
What does deferred taxes mean?: Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.